Pregnancy Clinical Trial
— PROSPEROOfficial title:
Program of Research for the Optimization of a Supervised Patient Pathway for Expectant According to Risk in Obstetrics
NCT number | NCT02593292 |
Other study ID # | 69HCL14_0454 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 5, 2016 |
Est. completion date | July 2018 |
Verified date | February 2019 |
Source | Hospices Civils de Lyon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This French multicentre open-label randomized trial will test the hypothesis that a coordinated health circuit based on obstetric risks, backed up by an electronic patient care reporting information system will optimize the continuum of pregnancy care monitoring. The electronic patient care reporting information system will be shared between patients, private practice physicians/midwifes, hospital physicians/midwifes and supervised by a coordinating midwife.
Status | Completed |
Enrollment | 1532 |
Est. completion date | July 2018 |
Est. primary completion date | July 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - patients over the age of majority, - enrolled in one of the two maternity hospitals in the study before 12 weeks of amenorrhea (SA) and 6 days (j) of age, - affiliated to the National Health Insurance Fund of the country within the regional level health insurance - have an internet access Exclusion Criteria: - illiterate patients, - non-French speakers, - under the age of majority, - refusing to participate, - without internet access, - followed by one of these maternity wards but delivering else where, - whose pregnancy ended in a miscarriage early or late (before 21 weeks of amenorrhea (SA) and 6 days (J) over). |
Country | Name | City | State |
---|---|---|---|
France | Hôpital Femme Mère Enfant | Bron | |
France | Hospices Civils de Lyon | Lyon |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of patients'pathway approved as compliant in the intervention group compared to the control group. | Compliant patient pathways are those for which all actions (medical visits, examinations, …) recommended during pregnancy, according to the specific risk factors of each patient, will have been made. | at the end of pregnancy | |
Secondary | rate of severe maternal morbidity and mortality as defined by the EPIdémiologie de la MOrbidité Maternelle Sévère (EPINOMS) project | From 22 completed weeks (154 days) of gestation to seven completed days after birth | ||
Secondary | rate of perinatal morbidity-mortality as defined by the Organization, Practices Evaluation in perinatal Network | From 22 completed weeks (154 days) of gestation to seven completed days after birth | ||
Secondary | completeness of all hospital medical records | completeness of hospital medical records compared to electronic patient-reported outcome (ePRO). | the end of pregnancy (the date of delivery) | |
Secondary | health care costs | Number of medical visits and hospitalization | one week from the date of delivery | |
Secondary | health care costs | duration of medical visits and hospitalization | one week from the date of delivery | |
Secondary | patients' satisfaction : Qualitative evaluation by interview | Qualitative evaluation of patients' satisfaction and adherence by interview and/or focus groups. Quantitative evaluation of patients' satisfaction and anxiety by the hospital anxiety and depression scale and other validated's patient satisfaction forms | at the end of pregnancy | |
Secondary | patients' satisfaction : Quantitative evaluation by the hospital anxiety and depression scale | Quantitative evaluation of patients' satisfaction and anxiety by the hospital anxiety and depression scale | at the end of pregnancy | |
Secondary | patients' satisfaction : Qualitative evaluation by interview | Qualitative evaluation of patients' satisfaction and adherence by interview and/or focus groups. | within one week from the date of delivery | |
Secondary | patients' satisfaction : Quantitative evaluation by the hospital anxiety and depression scale | Quantitative evaluation of patients' satisfaction and anxiety by the hospital anxiety and depression scale and other validated's patient satisfaction forms | within one week from the date of delivery | |
Secondary | types of delivery | rate of vaginal delivery, instrumental extraction delivery, Caesarean delivery | within one week from the date of delivery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Terminated |
NCT02537145 -
PregnanT Moms Measure - Do-It-Yourself Health Monitoring and Simulation of Health in Pregnant Women
|